|
Nitrosamine impurities of related substances of API's
|
|
5
|
362
|
July 11, 2024
|
|
Control limit of Nitrosamines and N-nitroso compounds
|
|
2
|
285
|
July 8, 2024
|
|
Non-mutagenic, carcinogenic impurities
|
|
3
|
388
|
June 30, 2024
|
|
Hexamethyldisilazane (HMDS) can form Nitrosamine Impurity?
|
|
6
|
297
|
June 27, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
18
|
2306
|
June 19, 2024
|
|
Tetrazole nitrosamines
|
|
1
|
206
|
June 13, 2024
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
384
|
June 4, 2024
|
|
AI limit of API having very law MDD
|
|
1
|
260
|
May 27, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
21
|
1353
|
May 22, 2024
|
|
Category 5 NDSRIs- CPCA tool
|
|
2
|
385
|
May 20, 2024
|
|
Nitrosamine in Azathioprine
|
|
4
|
757
|
May 14, 2024
|
|
APIC NA Risk Assessment Template
|
|
5
|
2671
|
May 11, 2024
|
|
Autonomous CPCA Web-based calculator FREE
|
|
28
|
4480
|
May 2, 2024
|
|
N-nitroso-rivaroxaban amide
|
|
5
|
1038
|
April 27, 2024
|
|
Risk Analysis for Ergotamine Tartrate
|
|
4
|
369
|
April 22, 2024
|
|
Nitrosamines: A new systematic review
|
|
11
|
2773
|
April 14, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
2412
|
April 3, 2024
|
|
AI difference between FDA and EMA, HC and TGA
|
|
0
|
930
|
March 22, 2024
|
|
N-Nitrosamine impurity of heterocyclic aromatic ring
|
|
16
|
2983
|
March 22, 2024
|
|
Nitroso amines quantification in drugs which are having MDD Value more than 10.0g/Day
|
|
2
|
329
|
March 20, 2024
|
|
New Validated LC-MS Method Development and Estimation of Nitrosamine impurities in Canaglifozin -Pub
|
|
0
|
560
|
February 16, 2024
|
|
N- nitroso Nitazoxanide
|
|
1
|
410
|
February 8, 2024
|
|
Reflective Beginnings: We have to be in the driver's seat
|
|
4
|
526
|
January 9, 2024
|
|
N-nitroso Torasemide Impurity formation and control
|
|
23
|
1692
|
January 5, 2024
|
|
Redefining Nitrosamine Risks: A Fresh Perspective on Pharmaceuticals -Pub
|
|
16
|
2116
|
December 17, 2023
|
|
Quantification of 13 N-Nitrosamines in Pharmaceuticals using SPE-LC-MS/MS
|
|
0
|
672
|
December 13, 2023
|
|
MDD for API/DP for Ophthalmic Formulation
|
|
4
|
760
|
December 12, 2023
|
|
10º encontro Farmacopeia Brasileira
|
|
0
|
465
|
November 30, 2023
|
|
Does atmospheric NO2 influence the formation of NDMA in metformin?
|
|
2
|
565
|
November 3, 2023
|
|
Vilazodone Nitrosamine
|
|
0
|
362
|
October 31, 2023
|